decisionhealth Newsletters, Part B News - 2013 Issue 1 (January)
Q1 drug prices face slight decrease overall with few bright spots
Subscribe or sign in to view the full article.
Article Overview
This article explains the CMS first-quarter 2013 average sales price update for Part B drugs and summarizes the overall direction of pricing changes, notable high-volume drug shifts, and code list additions and deletions. It is useful for billers, coders, reimbursement staff, and pharmacy-related revenue cycle teams who need to monitor quarterly drug pricing updates and code set changes. The piece also notes the status of a planned pricing policy change and includes an update correcting the added and deleted codes list.
Why This Topic Matters
Quarterly CMS drug pricing updates can affect reimbursement expectations, charge capture, and billing workflows for frequently used physician-administered drugs. Understanding which codes were added, removed, or changed helps practices and facilities stay current with Medicare billing references.
Article Sections
-
Drug billing
Overview of the quarterly CMS drug pricing update and general movement in drug prices for the period. The section provides context for reimbursement trends and the scope of the list.
-
Notable price changes and high-volume drugs
Discussion of selected drugs with larger relative changes and a summary of pricing movement among commonly used, high-volume drugs. The section focuses on broad pricing patterns across commonly billed medications.
-
Code deletions and additions
Summary of drug billing codes removed from and added to the CMS list for the quarter. The section covers list maintenance and update activity affecting billing references.
-
Policy update
Brief note on the status of a planned CMS pricing policy shift and the timing of further information. The section addresses administrative guidance rather than drug-specific pricing changes.
What You Will Learn
- How CMS quarterly drug pricing updates affect billed drug services
- What broad pricing trends were reported for the first quarter of 2013
- Which categories of drug codes were added to or removed from the CMS list
- Why quarterly drug price and code updates matter for reimbursement workflows
- What general policy issue CMS said would be addressed in future guidance
Who Should Read This
- Medical coders
- Billers and reimbursement staff
- Physician office staff
- Hospital outpatient revenue cycle teams
- Pharmacy billing teams
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com